Selected research
Market Outlook & Growth Opportunities
Global Biopharmaceutical Temperature Controlled Packaging Market Outlook and Growth Opportunities 2026
Market perspective
The global Biopharmaceutical Temperature Controlled Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Biopharmaceutical Temperature Controlled Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biopharmaceutical Temperature Controlled Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biopharmaceutical Temperature Controlled Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Biopharmaceutical Temperature Controlled Packaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Biopharmaceutical Temperature Controlled Packaging market include Sonoco Products Company, Envirotainer, Pelican Biothermal, Cryopak, DS Smith Pharma, Cold Chain Technologies, Intelsius, CSafe and Softbox Systems, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Biopharmaceutical Temperature Controlled Packaging market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biopharmaceutical Temperature Controlled Packaging and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biopharmaceutical Temperature Controlled Packaging sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biopharmaceutical Temperature Controlled Packaging market size, projected growth trends, production technologies, key applications, and end-use industries.
Biopharmaceutical Temperature Controlled Packaging Segment by Company
Sonoco Products Company
Envirotainer
Pelican Biothermal
Cryopak
DS Smith Pharma
Cold Chain Technologies
Intelsius
CSafe
Softbox Systems
Va-Q-tec AG
Sofrigam
American Aerogel Corporation
EcoCool Gmbh
Aeris Dynamics
Dokasch
Hazgo
Beijing Roloo Technology CO.,Ltd
Insulated Products Corporation
Inmark Packaging
Cold Chain Tools
Exeltainer SL
Inno Cool Pvt Ltd
Cryo Store
Biopharmaceutical Temperature Controlled Packaging Segment by Type
Reusable Solutions
Single Use Solutions
Biopharmaceutical Temperature Controlled Packaging Segment by Application
Temperature-Sensitive Pharmaceuticals
Vaccines
Others
Biopharmaceutical Temperature Controlled Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Biopharmaceutical Temperature Controlled Packaging status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Biopharmaceutical Temperature Controlled Packaging market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Biopharmaceutical Temperature Controlled Packaging significant trends, drivers, influence factors in global and regions.
6. To analyze Biopharmaceutical Temperature Controlled Packaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical Temperature Controlled Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical Temperature Controlled Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical Temperature Controlled Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Biopharmaceutical Temperature Controlled Packaging market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biopharmaceutical Temperature Controlled Packaging industry.
Chapter 3: Detailed analysis of Biopharmaceutical Temperature Controlled Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Biopharmaceutical Temperature Controlled Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Biopharmaceutical Temperature Controlled Packaging in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Reusable Solutions
- Single Use Solutions
Applications
- Temperature-Sensitive Pharmaceuticals
- Vaccines
- Others
Companies covered
- Sonoco Products Company
- Envirotainer
- Pelican Biothermal
- Cryopak
- DS Smith Pharma
- Cold Chain Technologies
- Intelsius
- CSafe
- Softbox Systems
- Va-Q-tec AG
- Sofrigam
- American Aerogel Corporation
- EcoCool Gmbh
- Aeris Dynamics
- Dokasch
- Hazgo
- Beijing Roloo Technology CO.,Ltd
- Insulated Products Corporation
- Inmark Packaging
- Cold Chain Tools
- Exeltainer SL
- Inno Cool Pvt Ltd
- Cryo Store
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Biopharmaceutical Temperature Controlled Packaging Sales Value (2021-2032)
- 1.2.2 Global Biopharmaceutical Temperature Controlled Packaging Sales Volume (2021-2032)
- 1.2.3 Global Biopharmaceutical Temperature Controlled Packaging Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Biopharmaceutical Temperature Controlled Packaging Market Dynamics
- 2.1 Biopharmaceutical Temperature Controlled Packaging Industry Trends
- 2.2 Biopharmaceutical Temperature Controlled Packaging Industry Drivers
- 2.3 Biopharmaceutical Temperature Controlled Packaging Industry Opportunities and Challenges
- 2.4 Biopharmaceutical Temperature Controlled Packaging Industry Restraints
3 Biopharmaceutical Temperature Controlled Packaging Market by Company
- 3.1 Global Biopharmaceutical Temperature Controlled Packaging Company Revenue Ranking in 2025
- 3.2 Global Biopharmaceutical Temperature Controlled Packaging Revenue by Company (2021-2026)
- 3.3 Global Biopharmaceutical Temperature Controlled Packaging Sales Volume by Company (2021-2026)
- 3.4 Global Biopharmaceutical Temperature Controlled Packaging Average Price by Company (2021-2026)
- 3.5 Global Biopharmaceutical Temperature Controlled Packaging Company Ranking (2024-2026)
- 3.6 Global Biopharmaceutical Temperature Controlled Packaging Company Manufacturing Base and Headquarters
- 3.7 Global Biopharmaceutical Temperature Controlled Packaging Company Product Type and Application
- 3.8 Global Biopharmaceutical Temperature Controlled Packaging Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Biopharmaceutical Temperature Controlled Packaging Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Biopharmaceutical Temperature Controlled Packaging Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Biopharmaceutical Temperature Controlled Packaging Market by Type
- 4.1 Biopharmaceutical Temperature Controlled Packaging Type Introduction
- 4.1.1 Reusable Solutions
- 4.1.2 Single Use Solutions
- 4.2 Global Biopharmaceutical Temperature Controlled Packaging Sales Volume by Type
- 4.2.1 Global Biopharmaceutical Temperature Controlled Packaging Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Biopharmaceutical Temperature Controlled Packaging Sales Volume by Type (2021-2032)
- 4.2.3 Global Biopharmaceutical Temperature Controlled Packaging Sales Volume Share by Type (2021-2032)
- 4.3 Global Biopharmaceutical Temperature Controlled Packaging Sales Value by Type
- 4.3.1 Global Biopharmaceutical Temperature Controlled Packaging Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Biopharmaceutical Temperature Controlled Packaging Sales Value by Type (2021-2032)
- 4.3.3 Global Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type (2021-2032)
5 Biopharmaceutical Temperature Controlled Packaging Market by Application
- 5.1 Biopharmaceutical Temperature Controlled Packaging Application Introduction
- 5.1.1 Temperature-Sensitive Pharmaceuticals
- 5.1.2 Vaccines
- 5.1.3 Others
- 5.2 Global Biopharmaceutical Temperature Controlled Packaging Sales Volume by Application
- 5.2.1 Global Biopharmaceutical Temperature Controlled Packaging Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Biopharmaceutical Temperature Controlled Packaging Sales Volume by Application (2021-2032)
- 5.2.3 Global Biopharmaceutical Temperature Controlled Packaging Sales Volume Share by Application (2021-2032)
- 5.3 Global Biopharmaceutical Temperature Controlled Packaging Sales Value by Application
- 5.3.1 Global Biopharmaceutical Temperature Controlled Packaging Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Biopharmaceutical Temperature Controlled Packaging Sales Value by Application (2021-2032)
- 5.3.3 Global Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application (2021-2032)
6 Biopharmaceutical Temperature Controlled Packaging Regional Sales and Value Analysis
- 6.1 Global Biopharmaceutical Temperature Controlled Packaging Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Biopharmaceutical Temperature Controlled Packaging Sales by Region (2021-2032)
- 6.2.1 Global Biopharmaceutical Temperature Controlled Packaging Sales by Region: 2021-2026
- 6.2.2 Global Biopharmaceutical Temperature Controlled Packaging Sales by Region (2027-2032)
- 6.3 Global Biopharmaceutical Temperature Controlled Packaging Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Biopharmaceutical Temperature Controlled Packaging Sales Value by Region (2021-2032)
- 6.4.1 Global Biopharmaceutical Temperature Controlled Packaging Sales Value by Region: 2021-2026
- 6.4.2 Global Biopharmaceutical Temperature Controlled Packaging Sales Value by Region (2027-2032)
- 6.5 Global Biopharmaceutical Temperature Controlled Packaging Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Biopharmaceutical Temperature Controlled Packaging Sales Value (2021-2032)
- 6.6.2 North America Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Biopharmaceutical Temperature Controlled Packaging Sales Value (2021-2032)
- 6.7.2 Europe Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Biopharmaceutical Temperature Controlled Packaging Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Biopharmaceutical Temperature Controlled Packaging Sales Value (2021-2032)
- 6.9.2 South America Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Biopharmaceutical Temperature Controlled Packaging Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Country, 2025 VS 2032
7 Biopharmaceutical Temperature Controlled Packaging Country-level Sales and Value Analysis
- 7.1 Global Biopharmaceutical Temperature Controlled Packaging Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Biopharmaceutical Temperature Controlled Packaging Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Biopharmaceutical Temperature Controlled Packaging Sales by Country (2021-2032)
- 7.3.1 Global Biopharmaceutical Temperature Controlled Packaging Sales by Country (2021-2026)
- 7.3.2 Global Biopharmaceutical Temperature Controlled Packaging Sales by Country (2027-2032)
- 7.4 Global Biopharmaceutical Temperature Controlled Packaging Sales Value by Country (2021-2032)
- 7.4.1 Global Biopharmaceutical Temperature Controlled Packaging Sales Value by Country (2021-2026)
- 7.4.2 Global Biopharmaceutical Temperature Controlled Packaging Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.9.2 France Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.16.2 China Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.19.2 India Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Biopharmaceutical Temperature Controlled Packaging Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Biopharmaceutical Temperature Controlled Packaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Sonoco Products Company
- 8.1.1 Sonoco Products Company Company Information
- 8.1.2 Sonoco Products Company Business Overview
- 8.1.3 Sonoco Products Company Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Sonoco Products Company Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.1.5 Sonoco Products Company Recent Developments
- 8.2 Envirotainer
- 8.2.1 Envirotainer Company Information
- 8.2.2 Envirotainer Business Overview
- 8.2.3 Envirotainer Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Envirotainer Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.2.5 Envirotainer Recent Developments
- 8.3 Pelican Biothermal
- 8.3.1 Pelican Biothermal Company Information
- 8.3.2 Pelican Biothermal Business Overview
- 8.3.3 Pelican Biothermal Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Pelican Biothermal Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.3.5 Pelican Biothermal Recent Developments
- 8.4 Cryopak
- 8.4.1 Cryopak Company Information
- 8.4.2 Cryopak Business Overview
- 8.4.3 Cryopak Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Cryopak Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.4.5 Cryopak Recent Developments
- 8.5 DS Smith Pharma
- 8.5.1 DS Smith Pharma Company Information
- 8.5.2 DS Smith Pharma Business Overview
- 8.5.3 DS Smith Pharma Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.5.4 DS Smith Pharma Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.5.5 DS Smith Pharma Recent Developments
- 8.6 Cold Chain Technologies
- 8.6.1 Cold Chain Technologies Company Information
- 8.6.2 Cold Chain Technologies Business Overview
- 8.6.3 Cold Chain Technologies Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Cold Chain Technologies Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.6.5 Cold Chain Technologies Recent Developments
- 8.7 Intelsius
- 8.7.1 Intelsius Company Information
- 8.7.2 Intelsius Business Overview
- 8.7.3 Intelsius Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Intelsius Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.7.5 Intelsius Recent Developments
- 8.8 CSafe
- 8.8.1 CSafe Company Information
- 8.8.2 CSafe Business Overview
- 8.8.3 CSafe Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.8.4 CSafe Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.8.5 CSafe Recent Developments
- 8.9 Softbox Systems
- 8.9.1 Softbox Systems Company Information
- 8.9.2 Softbox Systems Business Overview
- 8.9.3 Softbox Systems Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Softbox Systems Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.9.5 Softbox Systems Recent Developments
- 8.10 Va-Q-tec AG
- 8.10.1 Va-Q-tec AG Company Information
- 8.10.2 Va-Q-tec AG Business Overview
- 8.10.3 Va-Q-tec AG Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Va-Q-tec AG Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.10.5 Va-Q-tec AG Recent Developments
- 8.11 Sofrigam
- 8.11.1 Sofrigam Company Information
- 8.11.2 Sofrigam Business Overview
- 8.11.3 Sofrigam Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Sofrigam Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.11.5 Sofrigam Recent Developments
- 8.12 American Aerogel Corporation
- 8.12.1 American Aerogel Corporation Company Information
- 8.12.2 American Aerogel Corporation Business Overview
- 8.12.3 American Aerogel Corporation Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.12.4 American Aerogel Corporation Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.12.5 American Aerogel Corporation Recent Developments
- 8.13 EcoCool Gmbh
- 8.13.1 EcoCool Gmbh Company Information
- 8.13.2 EcoCool Gmbh Business Overview
- 8.13.3 EcoCool Gmbh Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.13.4 EcoCool Gmbh Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.13.5 EcoCool Gmbh Recent Developments
- 8.14 Aeris Dynamics
- 8.14.1 Aeris Dynamics Company Information
- 8.14.2 Aeris Dynamics Business Overview
- 8.14.3 Aeris Dynamics Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Aeris Dynamics Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.14.5 Aeris Dynamics Recent Developments
- 8.15 Dokasch
- 8.15.1 Dokasch Company Information
- 8.15.2 Dokasch Business Overview
- 8.15.3 Dokasch Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Dokasch Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.15.5 Dokasch Recent Developments
- 8.16 Hazgo
- 8.16.1 Hazgo Company Information
- 8.16.2 Hazgo Business Overview
- 8.16.3 Hazgo Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Hazgo Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.16.5 Hazgo Recent Developments
- 8.17 Beijing Roloo Technology CO.,Ltd
- 8.17.1 Beijing Roloo Technology CO.,Ltd Company Information
- 8.17.2 Beijing Roloo Technology CO.,Ltd Business Overview
- 8.17.3 Beijing Roloo Technology CO.,Ltd Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Beijing Roloo Technology CO.,Ltd Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.17.5 Beijing Roloo Technology CO.,Ltd Recent Developments
- 8.18 Insulated Products Corporation
- 8.18.1 Insulated Products Corporation Company Information
- 8.18.2 Insulated Products Corporation Business Overview
- 8.18.3 Insulated Products Corporation Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Insulated Products Corporation Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.18.5 Insulated Products Corporation Recent Developments
- 8.19 Inmark Packaging
- 8.19.1 Inmark Packaging Company Information
- 8.19.2 Inmark Packaging Business Overview
- 8.19.3 Inmark Packaging Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Inmark Packaging Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.19.5 Inmark Packaging Recent Developments
- 8.20 Cold Chain Tools
- 8.20.1 Cold Chain Tools Company Information
- 8.20.2 Cold Chain Tools Business Overview
- 8.20.3 Cold Chain Tools Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.20.4 Cold Chain Tools Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.20.5 Cold Chain Tools Recent Developments
- 8.21 Exeltainer SL
- 8.21.1 Exeltainer SL Company Information
- 8.21.2 Exeltainer SL Business Overview
- 8.21.3 Exeltainer SL Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.21.4 Exeltainer SL Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.21.5 Exeltainer SL Recent Developments
- 8.22 Inno Cool Pvt Ltd
- 8.22.1 Inno Cool Pvt Ltd Company Information
- 8.22.2 Inno Cool Pvt Ltd Business Overview
- 8.22.3 Inno Cool Pvt Ltd Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.22.4 Inno Cool Pvt Ltd Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.22.5 Inno Cool Pvt Ltd Recent Developments
- 8.23 Cryo Store
- 8.23.1 Cryo Store Company Information
- 8.23.2 Cryo Store Business Overview
- 8.23.3 Cryo Store Biopharmaceutical Temperature Controlled Packaging Sales, Value and Gross Margin (2021-2026)
- 8.23.4 Cryo Store Biopharmaceutical Temperature Controlled Packaging Product Portfolio
- 8.23.5 Cryo Store Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Biopharmaceutical Temperature Controlled Packaging Value Chain Analysis
- 9.1.1 Biopharmaceutical Temperature Controlled Packaging Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Biopharmaceutical Temperature Controlled Packaging Sales Mode & Process
- 9.2 Biopharmaceutical Temperature Controlled Packaging Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Biopharmaceutical Temperature Controlled Packaging Distributors
- 9.2.3 Biopharmaceutical Temperature Controlled Packaging Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst